Proscia and Unilabs have established a strategic partnership to accelerate the adoption of artificial intelligence (AI) in routine pathology practice.
Through the collaboration, Unilabs will validate the efficacy of Proscia’s computational pathology applications and deploy them into its high-throughput workflows, improving diagnostic quality and reducing turnaround times to benefit patients and clinicians.
Proscia will bring its experience building AI applications that perform across laboratory settings to the centre of the partnership. It will collaborate with Unilabs to create de-identified datasets, using the latest technology to adhere with data protection regulations, for developing AI solutions that drive meaningful quality and productivity gains. Unilabs will also test the utility of Proscia’s computational applications, generating clinical and economic evidence on their capacity to achieve their intended purposes.
Unilabs will innovate its service offerings through the partnership by beginning to implement computational pathology into its routine workflows, leveraging Proscia’s suite of AI applications. Unilabs will initially deploy DermAI, which classifies images of skin biopsies, displaying more than 200 diagnoses with a high degree of accuracy, to study the application’s impact on its high-throughput pathology operations.